SynthesisWorld journal of urology2018
'Prostate Cancer Risk Calculator' mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS).
Synthesis in World journal of urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- A Review of Mortality Risk Prediction Models in Smartphone Applications.Journal of medical systems · 2021Pooled it
- Pooled it
- Smartphone Apps Targeting Alcohol and Illicit Substance Use: Systematic Search in in Commercial App Stores and Critical Content Analysis.JMIR mHealth and uHealth · 2019Pooled it
- Developing and Testing a Smartphone Application to Enhance Adherence to Voice Therapy: A Pilot Study.International journal of environmental research and public health · 2023Trial
- A novel smartphone app to change risk behaviors of women after gestational diabetes: A randomized controlled trial.PloS one · 2022Trial
- A Smartphone App (TRIANGLE) to Change Cardiometabolic Risk Behaviors in Women Following Gestational Diabetes Mellitus: Intervention Mapping Approach.JMIR mHealth and uHealth · 2021Trial
- Mobile App Rating Scale for Health Care Professionals to Assess the Quality of mHealth Apps: Questionnaire Development and Psychometric Analysis.JMIR mHealth and uHealth · 2026Article
- Validity and reliability assessment of the Persian version of the User Mobile Application Rating Scale.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2026Article
- Evaluation of Mobile Intermittent Fasting Applications in Chinese App Stores: Quality Evaluations and Content Analysis.JMIR mHealth and uHealth · 2025Article
- Users' Needs for Mental Health Apps: Quality Evaluation Using the User Version of the Mobile Application Rating Scale.JMIR mHealth and uHealth · 2025Article
- Persian adaptation and validation of the user version of The Mobile Application Rating Scale (uMARS).PloS one · 2025Article
- Nutrition Management Miniprograms in WeChat: Evaluation of Functionality and Quality.JMIR human factors · 2024Observational
- "Internet+Nursing Service" Mobile Apps in China App Stores: Functionality and Quality Assessment Study.JMIR mHealth and uHealth · 2024Article
- Breast cancer-related apps in Google Play and App store: evaluate their functionality and quality.Journal of cancer survivorship : research and practice · 2023Article
- Alberta Rating Index for Apps: Study of Reliability and Validity.Canadian journal of occupational therapy. Revue canadienne d'ergotherapie · 2022Article
- Turkish Validation of the User Version of the Mobile Application Rating Scale.Turkish journal of urology · 2022Article
- Parents' Experience With a Mobile Health Intervention to Influence Human Papillomavirus Vaccination Decision Making: Mixed Methods Study.JMIR pediatrics and parenting · 2022Article
- A novel mHealth App (RyPros) for prostate cancer management: an accessibility and acceptability study.Translational andrology and urology · 2021Article
- Evaluating Quality, Usability, Evidence-Based Content, and Gamification Features in Mobile Learning Apps Designed to Teach Children Basic Life Support: Systematic Search in App Stores and Content Analysis.JMIR mHealth and uHealth · 2021Article
- Prostate Cancer Risk Calculator Apps in a Taiwanese Population Cohort: Validation Study.Journal of medical Internet research · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe use of mobile phone applications (Apps) has modernised the conventional practice of medicine. The diagnostic ability of the current Apps in prostate specific antigen monitoring, and its diagnostic ability within prostate cancer (PCa) risk calculators have not yet been appraised. We aimed to review, rate and assess the everyday functionality, and utility of all the currently available PCa risk calculator Apps.
methodsA systematic search on iTunes, Google Play Store, Blackberry World and Windows Apps Store, was performed on 23/11/2017, using the search term 'prostate cancer risk calculator'. After applying the exclusion criteria, each App was individually assessed and rated using pre-set criteria and grading was performed using the validated uMARS scale.
resultsIn total, 83 Apps were retrieved. After applying our exclusion criteria, only 9 Apps were relevant, with 2 duplicated, and the remaining 7 were suitable for critical review. Data sizes ranged from 414 kb to 10.1 Mb. The cost of the Apps ranged from South African rand (ZAR) 0.00 to ZAR 29.99. The overall mean category uMARS scores ranged from 2.8/5 to 4.5/5. Apps such as Rotterdam Prostate Cancer Risk Calculator, Coral-Prostate Cancer Nomogram Calculator and CPC Risk Calculator, performed the best.
conclusionsThe current PCa risk calculator mobile Apps available may be beneficial in counselling the concerned at risk patient. These Apps have potential to assist both the patient and the urologist alike. The PCa risk calculator App 'predictability' may be further enhanced by the incorporation of newly validated risk factors and predictors for PCa.
Indexed as
Identifiers
29222595What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.